Santa Clara, CA March 15, 2020 — Cephasonics, a leader in advanced ultrasound technology and systems, today announced that the United States Patent and Trademark Office (USPTO) has issued a new patent (U.S. Patent No. 10,499,884 ) to Cephasonics Ultrasound for Ultrasound Systems and Methods for Searching for a First Object within a Second Object Using a Dynamic Hardware Scheduler Micro-controller. The invention relates to ultrasound scanning and particularly to ultrasound scanning using a plurality of beams. This expands Cephasonics patent portfolio to 8 for technology used in Cephasonics family of ultrasound development and OEM systems.
Today, most ultrasound systems have limited, fixed functionality and require sophisticated user control. Most ultrasound systems cannot provide multiple simultaneous functions. For example, an operator of a typical ultrasound system is required to be skilled in the operation of the machine and capable of directing beams to the desired bodily objects. As a result, the use of such systems is limited by available human resources. And, even in the case of a skilled person, it might prove a challenge to locate an object on or within another object.
This patent covers Cephasonics technology that enables development of ultrasound systems, which can automatically find and recognize an object such as a tumor or cyst within another object such as an organ in the body without requiring an operator to be skilled in the use of the ultrasound apparatus. This patent extends 3 other patents issued to Cephasonics: A System and Method for Automatically Adjusting Beams to Scan a Desired Object in a Body”, “A Method for Scheduling Events of an Array of Ultrasound Transmitters Using a Timing Wheel”, and “A Dynamic Hardware Schedule Controller.”
Cephasonics CEO, Richard Tobias commented that, “this patent advances our leadership in ultrasound AI-based applications that can locate, recognize and characterize objects within the body.” He also stated that “for our partners who are developing new ultrasound products, this also enhances our Cephasonics platform in helping them create and deliver unique value and dramatically expand where and how ultrasound can be used.”